Dan Brennan
Stock Analyst at TD Cowen
(4.13)
# 518
Out of 4,987 analysts
110
Total ratings
53.93%
Success rate
13.33%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NEO NeoGenomics | Maintains: Buy | $10 → $12 | $8.11 | +47.97% | 7 | Sep 12, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $13 → $15 | $12.82 | +17.00% | 1 | Aug 6, 2025 | |
| CAI Caris Life Sciences | Initiates: Buy | $32 | $33.53 | -4.56% | 1 | Jul 14, 2025 | |
| GH Guardant Health | Maintains: Buy | $56 → $60 | $57.19 | +4.91% | 2 | May 1, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $135 → $110 | $127.92 | -14.01% | 4 | May 1, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Neutral | $8 → $2.5 | $2.81 | -11.03% | 4 | Mar 21, 2025 | |
| TEM Tempus AI | Reinstates: Buy | $74 | $86.45 | -14.40% | 2 | Feb 5, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $82 → $86 | $52.38 | +64.18% | 6 | Nov 26, 2024 | |
| NTRA Natera | Maintains: Buy | $155 → $175 | $175.43 | -0.25% | 4 | Nov 13, 2024 | |
| CRL Charles River Laboratories International | Maintains: Buy | $240 → $250 | $152.72 | +63.70% | 5 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $72 → $70 | $32.11 | +118.00% | 1 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $166 → $177 | $100.87 | +75.47% | 12 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $141 → $144 | $85.39 | +68.64% | 3 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $363 → $410 | $303.68 | +35.01% | 3 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $315 | $192.94 | +63.26% | 5 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $153 → $160 | $126.72 | +26.26% | 12 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $30 | $7.40 | +305.41% | 1 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $31 | $12.40 | +150.00% | 3 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $648 → $658 | $472.64 | +39.22% | 12 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $44.21 | +15.36% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $56 | $6.21 | +801.77% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $57 → $32 | $12.86 | +148.83% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $163.48 | +233.99% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $3.68 | +90.22% | 1 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $1.23 | +1,119.51% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $175.21 | +32.41% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,273.96 | -30.92% | 3 | Oct 7, 2020 |
NeoGenomics
Sep 12, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $8.11
Upside: +47.97%
Adaptive Biotechnologies
Aug 6, 2025
Maintains: Buy
Price Target: $13 → $15
Current: $12.82
Upside: +17.00%
Caris Life Sciences
Jul 14, 2025
Initiates: Buy
Price Target: $32
Current: $33.53
Upside: -4.56%
Guardant Health
May 1, 2025
Maintains: Buy
Price Target: $56 → $60
Current: $57.19
Upside: +4.91%
GeneDx Holdings
May 1, 2025
Maintains: Buy
Price Target: $135 → $110
Current: $127.92
Upside: -14.01%
Maravai LifeSciences Holdings
Mar 21, 2025
Maintains: Neutral
Price Target: $8 → $2.5
Current: $2.81
Upside: -11.03%
Tempus AI
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $86.45
Upside: -14.40%
Exact Sciences
Nov 26, 2024
Maintains: Buy
Price Target: $82 → $86
Current: $52.38
Upside: +64.18%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $175.43
Upside: -0.25%
Charles River Laboratories International
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $152.72
Upside: +63.70%
Nov 6, 2024
Maintains: Hold
Price Target: $72 → $70
Current: $32.11
Upside: +118.00%
Nov 5, 2024
Maintains: Buy
Price Target: $166 → $177
Current: $100.87
Upside: +75.47%
Nov 5, 2024
Maintains: Buy
Price Target: $141 → $144
Current: $85.39
Upside: +68.64%
Nov 4, 2024
Maintains: Hold
Price Target: $363 → $410
Current: $303.68
Upside: +35.01%
Oct 23, 2024
Maintains: Buy
Price Target: $310 → $315
Current: $192.94
Upside: +63.26%
Aug 22, 2024
Maintains: Buy
Price Target: $153 → $160
Current: $126.72
Upside: +26.26%
Aug 7, 2024
Maintains: Hold
Price Target: $28 → $30
Current: $7.40
Upside: +305.41%
Jul 29, 2024
Maintains: Buy
Price Target: $28 → $31
Current: $12.40
Upside: +150.00%
Jul 25, 2024
Maintains: Buy
Price Target: $648 → $658
Current: $472.64
Upside: +39.22%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $44.21
Upside: +15.36%
May 13, 2024
Initiates: Buy
Price Target: $56
Current: $6.21
Upside: +801.77%
May 1, 2024
Downgrades: Hold
Price Target: $57 → $32
Current: $12.86
Upside: +148.83%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $163.48
Upside: +233.99%
May 31, 2023
Initiates: Outperform
Price Target: $7
Current: $3.68
Upside: +90.22%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $1.23
Upside: +1,119.51%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $175.21
Upside: +32.41%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,273.96
Upside: -30.92%